Cardinal Health

Mountain View – – October 14, 2026 -- Level AI has appointed Shane Abeyratne, Senior Vice President of Global Business & Finance Services at Cardinal Health, as the second member of its CX Advisory Board, which launched in August.

Board convenes Fortune 500 leaders to set AI frameworks for contact centers

The CX Advisory Board brings together senior technology and customer experience executives from Fortune 500 companies. Its remit is to develop shared frameworks for how AI is deployed, measured and governed in enterprise customer operations.

Level AI said the Board will add members over the coming months. It is prioritizing executives responsible for large-scale customer contact operations.

Burlington – October 12, 2026 -- Eighty-six percent of 21 heart failure patients at imminent risk of hospital admission were decongested at home without hospitalization using SQ Innovation's subcutaneous furosemide product Lasix ONYU, according to interim results from the investigator-sponsored Gator SCALES-WHF study.

Three patients were admitted within 30 days for additional treatment. The data were presented on October 11 at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2026 in Phoenix, Arizona.

University of Florida study tests same-day home treatment pathway

Gator SCALES-WHF is a prospective, open-label, single-arm, real-world study at the University of Florida in Gainesville. Principal Investigator Mustafa M. Ahmed, MD, leads the trial, and cardiology fellow Jude ElSaygh, MD, presented the interim data.

Laval – October 12, 2026 -- A six-month pilot of a standardized cirrhosis clinical pathway raised follow-up office visit adherence by 9.0% in relative terms, to 51.1% from 46.9%, across 4,251 patients in five community gastroenterology practices, Bausch Health Companies Inc. and its GI unit Salix Pharmaceuticals announced.

The results will be presented as a poster at the American College of Gastroenterology (ACG) Annual Scientific Meeting & Postgraduate Course, held October 9-14, 2026, in Nashville, Tennessee. The companies describe the findings as preliminary until presented and evaluated in peer-reviewed publications.

Pune – – September 25, 2026 -- The global N95 mask market is projected to grow from $3.27 billion in 2025 to $11.08 billion by 2034, a 14.52% compound annual growth rate, according to Maximize Market Research.

North America dominates as major respirator makers expand capacity

North America held the largest regional share in 2025, driven by hospital demand, workplace safety mandates, and infection-control requirements. Manufacturers including 3M, Honeywell, Moldex-Metric, Cardinal Health, and Medline Industries maintain significant production presence in the region, supporting its lead position through continued investment in respiratory-protection capacity.

Delray Beach, Fla. – September 11, 2026 -- The global medical supplies market is projected to grow from $194.76 billion in 2026 to $248.03 billion by 2031, a compound annual growth rate of 7.39%, according to new research from MarketsandMarkets.

Asia Pacific outpaces global growth rate as diagnostic demand accelerates

Asia Pacific is set to register the fastest regional CAGR at 10.2% through 2031, outstripping the global average as healthcare infrastructure expands across the region. By product type, infusion and injectable supplies will grow fastest at a 9.0% CAGR, while diagnostic supplies held the largest share in 2025 and are expected to post the quickest growth of any category over the forecast period, driven by rising chronic and infectious disease burdens and expanding preventive screening programs.